Treatment of Hemorrhagic Fever With Ribavirin
Clinical trial NCT04283513 · SUSPENDED
Trial details
- NCT number
- NCT04283513
- Sponsor
- U.S. Army Medical Research and Development Command
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2027-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.